1. Home
  2. MESH vs AUTL Comparison

MESH vs AUTL Comparison

Compare MESH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MESH

Meshflow Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.89

Market Cap

427.8M

Sector

N/A

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.44

Market Cap

431.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESH
AUTL
Founded
2025
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
427.8M
431.2M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
MESH
AUTL
Price
$9.89
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
72.1K
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.33
EPS
N/A
N/A
Revenue
N/A
$10,120,000.00
Revenue This Year
N/A
$669.62
Revenue Next Year
N/A
$79.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
496.00
52 Week Low
$9.88
$1.11
52 Week High
$9.94
$2.70

Technical Indicators

Market Signals
Indicator
MESH
AUTL
Relative Strength Index (RSI) 49.42 40.70
Support Level $9.88 $1.27
Resistance Level $9.91 $1.52
Average True Range (ATR) 0.00 0.11
MACD -0.00 -0.03
Stochastic Oscillator 50.00 0.96

Price Performance

Historical Comparison
MESH
AUTL

About MESH Meshflow Acquisition Corp. Class A Ordinary Shares

Meshflow Acquisition Corp is a blank check company.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: